BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 18936710)

  • 1. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis.
    Naitoh I; Nakazawa T; Ohara H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Sano H; Takada H; Joh T
    Pancreas; 2010 Jan; 39(1):e1-5. PubMed ID: 19924018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
    Nishimori I; Otsuki M
    Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.
    Kaji R; Takedatsu H; Okabe Y; Ishida Y; Sugiyama G; Yonemoto K; Mitsuyama K; Tsuruta O; Sata M
    J Gastroenterol Hepatol; 2012 Feb; 27(2):268-72. PubMed ID: 21929654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IgG4-related sclerosing disease].
    Kamisawa T; Zenimoto M; Obayashi T
    Rinsho Byori; 2009 Nov; 57(11):1113-9. PubMed ID: 20030180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
    Ghazale A; Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Clain JE; Pearson RK; Pelaez-Luna M; Petersen BT; Vege SS; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1646-53. PubMed ID: 17555461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.
    Takuma K; Kamisawa T; Igarashi Y
    Curr Opin Rheumatol; 2011 Jan; 23(1):80-7. PubMed ID: 21124090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission.
    Miura H; Miyachi Y
    JOP; 2009 Jul; 10(4):432-7. PubMed ID: 19581751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous extrapancreatic lesions in autoimmune pancreatitis.
    Takuma K; Kamisawa T; Anjiki H; Egawa N; Igarashi Y
    Intern Med; 2010; 49(6):529-33. PubMed ID: 20228586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis.
    Wang WL; Farris AB; Lauwers GY; Deshpande V
    Histopathology; 2009 Jun; 54(7):829-36. PubMed ID: 19635102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
    Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.
    Uehara T; Hamano H; Kawa S; Sano K; Honda T; Ota H
    Pathol Int; 2005 Jul; 55(7):405-11. PubMed ID: 15982215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy.
    Kamisawa T; Nakajima H; Egawa N; Funata N; Tsuruta K; Okamoto A
    Pancreatology; 2006; 6(1-2):132-7. PubMed ID: 16327291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera.
    Aoki S; Nakazawa T; Ohara H; Sano H; Nakao H; Joh T; Murase T; Eimoto T; Itoh M
    Histopathology; 2005 Aug; 47(2):147-58. PubMed ID: 16045775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG4 concentrations and IgG4-related sclerosing disease.
    Tabata T; Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K; Setoguchi K; Obayashi T; Sasaki T
    Clin Chim Acta; 2009 Oct; 408(1-2):25-8. PubMed ID: 19580797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4-positive sclerosing cholangitis following autoimmune pancreatitis with deranged CA19.9.
    Ong SL; Garcea G; Puls F; Richards C; Mulcahy K; Grant A; Dennison AR; Berry DP
    Int J Surg Pathol; 2011 Feb; 19(1):84-7. PubMed ID: 18611930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour.
    Cheung MT; Lo IL
    ANZ J Surg; 2008 Apr; 78(4):252-6. PubMed ID: 18366395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
    Igarashi H; Ito T; Oono T; Nakamura T; Fujimori N; Niina Y; Hijioka M; Uchida M; Lee R; Iwao R; Nakamura K; Kotoh K; Takayanagi R
    J Dig Dis; 2012 May; 13(5):274-9. PubMed ID: 22500790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.